Literature DB >> 10682995

Endpoints for homocysteine-lowering trials.

A G Bostom1, C Garber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10682995     DOI： 10.1016/S0140-6736(99)00437-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  Homocysteine levels in patients with stroke: clinical relevance and therapeutic implications.

Authors:  G J Hankey; J W Eikelboom
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Distribution and determinants of plasma homocysteine levels in rural Chinese twins across the lifespan.

Authors:  Yuelong Ji; Xiangyi Kong; Guoying Wang; Xiumei Hong; Xin Xu; Zhu Chen; Tami Bartell; Xiping Xu; Genfu Tang; Fanfan Hou; Yong Huo; Xiaobin Wang; Binyan Wang
Journal:  Nutrients       Date:  2014-12-18       Impact factor: 5.717
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.